Julia Lee, PA
Medical · Suwanee, GANPI 1093121964
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,906 of the $11,469 with a category attached, or 86.4%. It is spread thinly across 31 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 390 payments — averaging $29.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Regeneron Healthcare Solutions, Inc.$939
- Dermavant Sciences, Inc.$923
- Pfizer$828
- Lilly USA, LLC$638
- Galderma Laboratories, L.p.$581
- plus $5K from 25 others
What the payments were for
- Consulting fees$1,25011%
- Travel & lodging$40%
- Food & beverage$9,90686%
- Education$3093%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 75 | $2,689 |
| Regeneron Healthcare Solutions, Inc. | 30 | $939 |
| Dermavant Sciences, Inc. | 25 | $923 |
| Pfizer | 44 | $828 |
| Lilly USA, LLC | 20 | $638 |
| Galderma Laboratories, L.p. | 23 | $581 |
| LEO Pharma Inc. | 14 | $437 |
| Sanofi | 14 | $411 |
| Incyte Corporation | 14 | $408 |
| E.r. Squibb & Sons, L.L.C. | 21 | $382 |
| Johnson & Johnson | 18 | $376 |
| Novartis | 13 | $356 |
| UCB, Inc. | 11 | $322 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 9 | $262 |
| Organon | 6 | $250 |
| Arcutis Biotherapeutics, Inc. | 7 | $236 |
| Sun Pharmaceutical Industries Inc. | 9 | $186 |
| Boehringer Ingelheim | 5 | $185 |
| Amgen | 7 | $171 |
| Verrica Pharmaceuticals Inc. | 3 | $164 |
| VYNE Pharmaceuticals Inc. | 1 | $138 |
| Janssen Scientific Affairs, LLC | 1 | $136 |
| Almirall LLC | 7 | $127 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| EPI Health, LLC | 3 | $60 |
| Genentech USA, Inc. | 3 | $54 |
| Botanix SB Inc | 2 | $40 |
| Journey Medical Corporation | 1 | $26 |
| Biofrontera Inc. | 1 | $22 |
| Dermira, Inc. | 1 | $13 |
| Mayne Pharma Commercial LLC | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,469 in reported general payments places this provider in the 95th percentile of 950 medical providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 37 | $1,529 |
| Triamcinolone Acetonide | 22 | $106 |
| Doxycycline Hyclate | 11 | $75 |
Paid to pharmacies, not to this prescriber.
Other medical in Suwanee
- Tomas ChaoWoodstock$1.9M
- Kimberly OrleckAtlanta$727K
- Audrey GibsonGainesville$302K
- Lisa WeissCanton$283K
- Laura BushFayetteville$146K
- Michael KelleherMarietta$126K
- Juliena GigonMarietta$122K
- Felicia HoffmanRoswell$114K
- Sally BrumbillLithia Springs$110K
- Danna Dennis-CalderAtlanta$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.